| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Stock Research – Citigroup – Sandy Wyle's Decisions Haunt Current Shareholders |
|
Top Articles - Stock Research – Citigroup – Sandy Wyle's Decisions Haunt Current Shareholders
Our stock research has come up with an interesting concept for you to focus on. Citigroup is in the press these days because its stock price has failed to keep up with that of its competitors including Bank of America, Wells Fargo, and JP Morgan Chase. The chairman of Wells Fargo, Richard Kovacevich is acknowledged According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product to be the finest banking CEO in the business, but doesn’t receive the press because no one can pronounce his name. Citigroup is up about 17% under the current CEO while cross-town rival J.P. Morgan Chase has gained more than 40%, and Union Bank of Switzerland (UBS) more than doubled. Reliable Goldman Sachs is up ove ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in r 150%. Is anybody listening? You bet they are. Chuck Prince, who took over Citigroup after the departure of the fabulously successful Sandy Weill, is now getting excoriated by the financial press because Citigroup’s stock price has seriously lagged that of its rivals noted above. When you’re down, they kick dirt o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. n you as the saying goes. The press has gone out of its way to jump all over the firing of Todd Thomson who ran Citigroup’s wealth management division. Apparently the biggest recipient of the wealth management division was Mr. Thomson himself, who made extensive use of the bank’s private jet fleet, when he wasn’t to here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ling around town in his Lamborghini. Very conservative car for a banker, huh? Statements have been made that Thompson committed $5 million of Citigroup’s money to a new television program featuring CNBC’s Maria Bartiromo, and Hollywood A-List actor Robert Redford. If that doesn’t beat all, he had a wood burning fir d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro eplace installed in his office at Citigroup to keep warm while figuring out new projects to spend the bank’s money on. He flew to China with a group of Citigroup executives, and then left them to find their way back home, while he flew back with an undisclosed companion. I guess those corporate jets get cramped with ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc a couple more people aboard. What a guy, what a management team, what does any of this say about Citigroup’s inability to stay pace with its competitors financially after Sandy Weill’s departure, and Chuck Prince’s ascent to the helm of the ship? It says plenty, here’s why. Back in the 1930’s, the Federal governm easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nt under FDR decided to separate the banking industry from the investment industry. It was called the Glass-Steagall Act. Brokerage firms and banks had to make a decision. You could be a bank, or you could be a brokerage company. You could not be both. Firms like JP Morgan and company decided to remain a bank. The i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nvestment partners at JP Morgan walked out and formed Morgan Stanley, so that they could remain in the capital formation business. Only one company by law was allowed to remain in both functions. It was Brown Brothers Harriman. FDR specifically decided to do a favor for his supporter Averill Harriman who controlled and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the family bank. Just for your information, President Bush’s ancestral grandfather was a prominent banker at Brown Brothers. He ran the show, his name was Prescott Bush. For the next six decades it became apparent, separating the banking and investment functions was a good idea. Something else became apparent. The ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi mentality necessary to run a bank was radically different from the managerial expertise necessary to run a successful brokerage firm. In my 35 years of involvement with Wall Street, I have only seen one successful integration of a commercial bank with a Wall Street firm. Only Sandy Weill was able to pull it off, and ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a he did it by combining Citibank with Salomon Brothers, and Smith Barney. Weill also managed to get Bill Clinton to get the Glass-Steagall Act repealed so that Weill could fulfill his personal vision. No one else in history had been able to do it, and nobody else has successfully merged a bank with a brokerage firm dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod function, nobody. Prudential failed with Bache. Bank of America failed when it bought Charles Schwab and Company. Schwab and Company failed years later when it bought US Trust. Arguably the best managed company in America was General Electric under Jack Welch. GE and Welch failed when they took over Kidder Peabody. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin GE walked away a couple of years later with billions in losses. It seems that banks and brokerage firms just don’t mix. Brokerage firms and other commercial type entities like General Electric don’t mix either. The nature of risk is different for a bank versus a brokerage firm. Sandy Weill himself sold Shearson Le tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen man Brothers to American Express years ago. The merger failed once again, and Weill considered it the major setback of his career. It takes a certain type of manager to assess, and handle a brokerage firm’s risk versus a bank. This concept keeps coming home to haunt companies that try their hands at both. Is Citigr t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel oup a VICTIM of this MINDSET? We believe that they are. We believe that the historic inability of a bank management team to run a brokerage firm has now reared its head once again in results we are seeing at Citigroup. Chuck Prince, the handpicked successor to Sandy Weill upon Weill’s departure is a lawyer by train ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ing. The same is true for the new CEO of Home Depot. We believe that the experiences that legally trained minds endure, is wholly unsuited for the world of the superstar CEO’s which is now the norm among the Fortune 500. Citigroup for the last 15 years has had very large Mid East financial interests involved as sha y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products eholders. Those interests are now asserting themselves. They are demanding that the bank cut expenses. It’s really very simple. MONEY wants to make MONEY. Chuck Prince in turn has promoted former deputy Robert Druskin, as chief operating officer. They are actually referring to Druskin as the “expense czar”. In our . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de opinion, the actions taken so far will not be sufficient to reverse the lag that Citigroup is suffering from. Citigroup suffers an inability to mould historically disparate global operations together. They are not generating superior returns. Investment management, corporate lending, and wealth management just don’t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip jell, and hasn’t since the 1930’s. Extraordinary CEO’s and visionaries like Sandy Weill come along once in a generation, and Citigroup doesn’t look like it’s going to be blessed twice. Stay tune for more fireworks before this stock becomes a buy. Goodbye and Good Luck Richard Stoyeck http://www.stocksatbottom.co tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Seven Characteristics Of A True Entrepreneur Web Video: One Facet of the NEW Internet Marketing
|